Huntington National Bank’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-750
Closed -$17K 2049
2022
Q1
$17K Hold
750
﹤0.01% 1418
2021
Q4
$21K Buy
+750
New +$20.1K ﹤0.01% 1356
2016
Q2
Sell
-1,121
Closed -$223K 1512
2016
Q1
$223K Buy
1,121
+1,111
+11,110% +$82.2K 0.01% 610
2015
Q4
$1K Sell
10
-968
-99% -$109K ﹤0.01% 1609
2015
Q3
$174K Sell
978
-137
-12% -$31.9K ﹤0.01% 666
2015
Q2
$248K Sell
1,115
-6
-0.5% -$1.33K 0.01% 600
2015
Q1
$223K Buy
1,121
+537
+92% +$95.3K 0.01% 613
2014
Q4
$84K Buy
+584
New +$78.5K ﹤0.01% 974
2014
Q2
Sell
-2,610
Closed -$344K 1059
2014
Q1
$344K Buy
2,610
+1,943
+291% +$266K 0.01% 920
2013
Q4
$78K Sell
667
-244
-27% -$26.7K ﹤0.01% 964
2013
Q3
$95K Sell
911
-28
-3% -$2.73K ﹤0.01% 888
2013
Q2
$81K Buy
+939
New +$74K ﹤0.01% 920

Other funds holding BHC

Huntington National Bank's BHC Position: Q2 2022 in Review

Huntington National Bank sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 750 shares — an estimated $17K sold.

Huntington National Bank first reported a position in BHC in Q2 2013 and held it in 12 quarters. The position peaked at $344K in Q1 2014. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • Huntington National Bank reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • Huntington National Bank sold 750 Bausch Health shares in Q2 2022, an estimated $17K.
  • Huntington National Bank first reported a position in Bausch Health in Q2 2013 and held it in 12 quarters.
  • Huntington National Bank's Bausch Health position peaked at $344K in Q1 2014.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on Huntington National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.